Michele G.
- Country
- Italy
- Department
- PEDIATRIA
Research Overview
- Efficacy and Safety of Dupilumab in Pediatric Patients Aged 2 to <6 Years with Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze
- A 52-Week Randomized Double-Blind Trial Comparing CHF5993 (Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium Bromide) to Fluticasone Propionate/Salmeterol in Adolescents with Uncontrolled Asthma
Data & Insights
Has run more than one trial at 5 of 47 partner sites.
Specializations
Pediatric Respiratory Medicine
The investigator specializes in treating young children with respiratory tract conditions, with particular emphasis on early-onset asthma and asthmatic wheeze in patients aged 2 to under 6 years.
- Early-Onset Asthma Management
- Pediatric Respiratory Care
- Wheezing Disorders
The investigator's work focuses on evaluating innovative therapeutic approaches for uncontrolled asthma in very young children.
Therapeutic Innovation
The investigator demonstrates expertise in advanced biological therapies for pediatric respiratory conditions, exploring new treatment options for young children with severe or uncontrolled asthma.
- Biological Therapy Applications
- Novel Treatment Approaches
- Long-term Disease Management
Their research encompasses both efficacy assessment and safety evaluation in pediatric populations.
Clinical Outcomes
The investigator's work centers on reducing severe asthma exacerbations in young children and improving the management of uncontrolled respiratory conditions.
- Exacerbation Prevention
- Treatment Safety Profiles
- Long-term Disease Control
Their research aims to enhance therapeutic outcomes in pediatric respiratory medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.